

Aileen Health has taken on the critical challenge of accelerating the patient access to new therapies, particularly in the area of breast cancer. Our studies have shown that it can take decades before new therapies are reaching their peak sales, and if we accelerate the clinical adoption with 10 % we have saved thousands of lives and improved the quality for many more. By introducing an innovative tool that utilizes 4D (3D + time) generative AI our approach enables a prediction of future tumor states, and the comparison of treatment response beyond standard of care. This proactive capability enables clinicians to anticipate disease progression and optimize therapy selection, representing a substantial advance in the field with the potential to transform how treatment plans are designed and delivered.
Aileen Health was part of SHAPE in 2023 and is participating in FACTORY+ #8 (AplusB program) in 2023/24.